Adam Feldman, M.D., M.P.H.


Physician Investigator (Cl)
Urology, Mass General Research Institute
Assistant Professor of Surgery
Harvard Medical School
Assistant In Urology
Massachusetts General Hospital
MPH Harvard T. H Chan School of Public Health 2009
MD UMass Medical School 2000
MD University of Massachusetts Medical School 2000
biomarkers in prostate cancer; carcinoma transitional cell; congresses as topic; cystatin b; cystectomy; fusion biopsy; genitourinary cancer biomarkers; hemangiopericytoma; leiomyosarcoma; nanoparticles; penile neoplasms; penis; renal cell carcinoma; renal mass biopsy; urinary bladder neoplasms; urogenital neoplasms; urology Dr. Feldman is active in clinical and translational research in renal cell carcinoma, prostate cancer and bladder cancer. In RCC, he is interested in the clinical management and outcomes of the treatment of small renal masses. In prostate cancer, he is interested in biomarker discovery and evaluation and the appropriateness and utility of active surveillance for low risk disease.
Research lab website Publications Clinical Profile
afeldman@partners.org
6176431955

Charles River Plaza East
165 Cambridge Street
Boston, MA 02114